Stability of archived liquid‐based cervical cytologic specimens

Exfoliated cervical cell specimens collected in PreservCyt®, a methanol‐based medium used in ThinPrep® liquid‐based cytology, have been archived in epidemiologic studies. However, long‐term DNA stability and cytologic stability of these biospecimens have not been evaluated.

[1]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[2]  N. Kiviat,et al.  PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. , 1991, American journal of clinical pathology.

[3]  L. Mango,et al.  Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. , 1997, Revista panamericana de salud publica = Pan American journal of public health.

[4]  L. Mango,et al.  Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing , 1997, Cancer.

[5]  J Linder,et al.  Recent advances in thin‐layer cytology. , 1998, Diagnostic cytopathology.

[6]  M. Sherman,et al.  The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as preservCyt suspensions and as thinPrep slides , 1998, Cancer.

[7]  A. Maitra,et al.  Molecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology. , 2000, American journal of obstetrics and gynecology.

[8]  L. Koutsky Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. , 2000, Journal of the National Cancer Institute.

[9]  M. Plummer,et al.  Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.

[10]  L. Koutsky,et al.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. , 2000 .

[11]  S Wacholder,et al.  HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. , 2000, JAMA.

[12]  M. Schiffman,et al.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. , 2001, Journal of the National Cancer Institute.

[13]  M. Schiffman,et al.  Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. , 2001, JAMA.

[14]  Martin R. Johnson,et al.  Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real‐time polymerase chain reaction analysis , 2002, Cancer.